Chronic conditions news
Read the latest news on chronic conditions.
![woman uses asthma puffer]()
The Australian Government has listed a range of medicines for treating multiple sclerosis, asthma and diabetes on the Pharmaceutical Benefits Scheme (PBS). The listings will provide valuable support for more than 51,800 Australians living with these conditions, saving them up to $29,000 a year.
![young female doctor]()
The Government has added a life-changing new eczema medicine to the Pharmaceutical Benefits Scheme (PBS). The $270 million in funding to list the medicine will help up to 3,600 Australians over 12 years of age living with severe eczema.
![Embraced adult and child hands holding a red heart]()
The Government will invest $47 million over 4 years into a program to accelerate cutting-edge research into two of the most prominent health conditions that affect millions of Australians – diabetes and cardiovascular disease.
![Young boy with doctor listening to own heart]()
The Australian Government, together with the National Heart Foundation, has announced a further $12 million for research to improve treatment of people, including children, suffering cardiovascular disease and stroke.
![Embraced adult and child hands holding a red heart]()
The Australian Government is investing in vital research initiatives to tackle the nation’s two biggest killers — heart disease and stroke. This funding is the first round of disbursements from the Medical Research Future Fund’s (MRFF) Cardiovascular Health Mission.
![medical lab]()
More than one year on from the first ever National Action Plan for Endometriosis, the Australian Government is continuing to support women and girls with endometriosis.
![Woman at desk with laptop and office equipment]()
A new online directory will provide people living with chronic pain—and their health practitioners—with a comprehensive list of available services to help manage their conditions.
![Image of researcher with cell culture]()
The Australian Government is calling for proposals for $3 million in research to better understand the causes and improve diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
![ABS logo]()
The ABS’ Causes of Death, Australia, 2018 report notes suicide dropped one place to 14th leading cause of death overall. Rates of mortality due to heart disease and cerebrovascular disease also decreased, however these remain among the leading causes of death in Australia.
![Image of medicines and prescribed drugs]()
The Australian Government will invest over $40 million to provide affordable access to 2 new medicine listings through the Pharmaceutical Benefits Scheme (PBS). This will help Australians with opiate addiction and those suffering breathlessness throughout their final stages of life.
![Mother and baby image]()
The Australian Government is expanding access to a critically important medicine on the Pharmaceutical Benefits Scheme (PBS) that will help infants living with Cystic Fibrosis and save their families up to $300,000 per year.
![A $2.8 million focus on Diabetes]()
To mark National Diabetes Week, the Australian Government is investing $2.8 million to help prevent and treat diabetes-related conditions.
![November is Lung Cancer Awareness Month and from 1 November, Keytruda® will be listed on the PBS for first-line treatment of people with metastatic non-small cell lung cancer.]()
November is Lung Cancer Awareness Month and from 1 November, Keytruda® will be listed on the PBS for first-line treatment of people with metastatic non-small cell lung cancer.
![Launch of the National Action Plan for Endometriosis]()
The Australian Government will invest $4.7million in Australia’s first National Action Plan for Endometriosis
![Pharmacist filling a bottle of tablets]( "Pharmacist filling a bottle of tablets")
More than 3000 women will benefit from a new breast cancer medicine that has been listed on the Pharmaceutical Benefits Scheme (PBS).
